Recent News: Vermillion Announces Two Independent Publications Showing OVA1® (MIA- Multivariate Index Assay) Demonstrates Improved Ovarian Malignancy Risk Detection in African-American Women

CONTACT US to learn more or sign up for email alerts.

Our Products

How We’re Transforming Ovarian Cancer Detection

We concentrate our development of novel diagnostic tests for gynecologic disease, with an initial focus on ovarian cancer.